염증성 장 질환 동물 모델에서 황금탕과 감초사심탕의 효능 연구 = A Study of the Effectiveness of Hwanggeum-tang and Gamchosasim-tang in the Mice Model of Inflammatory Bowel Disease

다국어 초록 (Multilingual Abstract)

Objectives: This study investigates the mechanism of Hwanggeum-tang (HGT) and Gamchosasim-tang (GST) on inflammatory bowel disease (IBD). Methods: The mice (C57BL/6N) were treated with distilled water and 3% dextran sulfate sodium (DSS) to experimentally induce ulcerative colitis. The mice were divided into 7 groups of (6 mice: normal, negative control, positive control (with sulfasalazine), 4 experimental groups (with HGT and GST, respectively). RAW 264.7 cells were used for cell experiments. The experiment was conducted in two ways: in vitro and in vivo. Results: In the experimental group (HGT, GST) of in vitro experiments, NO production decreased, and significant changes in gene expression and protein activation were observed. The length of the colon recovered in the experimental groups (HGT, GST) of the in vivo experiment was longer than that of the negative control group, and the mucosal barrier was recovered. Sone significant changes in the amount of mRNA expression were partially observed, and significant changes in protein activation also were confirmed. Conclusions: HGT and GST are effective in treating IBD caused by DSS. In the same herbal preparation group, the higher the concentration, the better the experimental effect, and when the same concentration was tested, HGT was more effective than GST. Herbal medicine has a higher antioxidant effect than sulfasalazine, so it is also excellent for cell protection.

참고문헌 (Reference)

1 최준용, "항염증조절을 통한 자금정의 DSS 유도 궤양성 대장염 완화 효과" 대한한방내과학회 38 (38): 944-954, 2017

2 박은정, "암 치료 표적으로의 NAD(P)H Quinone Oxidoreductase 1 (NQO1)" 한국생명과학회 24 (24): 98-103, 2014

3 한동수, "다량의 복수가 주 증상으로 나타난 POEMS 증후군 1예" 대한소화기학회 40 (40): 1-1, 2002

4 차호열, "금은화 추출물의 항산화, 항염증 효과가 Dextran Sulfate Sodium으로 유도된 생쥐의 궤양성 대장염에 미치는 영향" 대한한방소아과학회 29 (29): 54-64, 2015

5 진윤태, "궤양성 대장염의 최신치료" 대한내과학회 76 (76): 654-660, 2009

6 최창환, "궤양성 대장염 치료 가이드라인" 대한소화기학회 59 (59): 118-140, 2012

7 강아미, "궤양성 대장염 유발 생쥐에 투여한 계지가용골모려탕의 치료효과" 대한한방내과학회 38 (38): 1021-1034, 2017

8 윤석빈, "黃芩이 LPS로 유발된 Raw 264.7 Cells의 염증인자에 미치는 영향" 대한본초학회 26 (26): 75-81, 2011

9 황주원, "陰結로 변증한 궤양성 대장염 환자의 平胃地楡湯加味方 치험 1례" 대한한방내과학회 28 (28): 972-977, 2007

10 Hu X, "胡希恕傷寒論講義" Fishwood 290-292, 2019

11 양동선, "甘草瀉心湯으로 호전된 베체트병 의증 환자 1례" 대한한방부인과학회 22 (22): 188-194, 2009

12 김의수, "烏梅丸과 烏梅가 DSS로 유발된 생쥐의 염증성 장 질환에 미치는 영향" 대한한방내과학회 36 (36): 284-296, 2015

13 서철훈, "濕熱痢로 변증한 궤양성 대장염 환자의 芍藥湯加味方 치험 2례" 대한한방내과학회 27 (27): 984-990, 2006

14 Department of gastrointestinal medicine Korean medicine, "gastrointestinal internal medicine" Gunja Publishing Co., Ltd 365-, 2008

15 Song HY, "Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)- induced inflammation in mice" 75 (75): 1348-1357, 2008

16 Schieven GL, "The biology of p38 kinase:a central role in inflammation" 5 (5): 921-928, 2005

17 김경조, "TNBS로 유발된 마우스 대장염모델에서 설파살라진, 육계와 시호 복합 추출물의 항염증 및 세포 자멸 개선효과" 한국응용생명화학회 60 (60): 227-234, 2017

18 Pender SL, "Suppression of T cell–mediated injury in human gut by interleukin 10:role of matrix metalloproteinases" 115 (115): 573-583, 1998

19 Gamble J, "Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor" 82 (82): 8667-8671, 1985

20 Mitchell TJ, "Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas" 114 (114): 301-312, 2005

21 한민호, "RAW 246.7 대식세포 모델에서 고삼, 감초, 백선피 에탄올 추출물 및 추출복합물의 항염증 효능 비교" 한국생명과학회 24 (24): 329-335, 2014

22 Ishiguro K, "Paeonol attenuates TNBS-induced colitis by inhibiting NF-κB and STAT1 transactivation" 217 (217): 35-42, 2006

23 Kim YR, "Oncogenic NFE2L2 mutations in squamous cell carcinomas of esophagus and skin" 220 (220): 446-451, 2010

24 Nathan C, "Nitric oxide synthases:roles, tolls, and controls" 78 (78): 915-918, 1994

25 Belvisi M, "Nitric oxide synthase activity is elevated in inflammatory lung disease in humans" 283 (283): 255-258, 1995

26 Stuehr DJ, "Mammalian nitrate biosynthesis:mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide" 82 (82): 7738-7742, 1985

27 Thalhamer T, "MAPKs and their relevance to arthritis and inflammation" 47 (47): 409-414, 2008

28 Schotte H, "Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis" 43 (43): 960-964, 2004

29 Su YW, "Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down- regulating the MAPK, NF-κB and AP-1 signaling pathways" 11 (11): 1166-1172, 2011

30 Benvenistem EN, "Immunology of the Nervous System" Oxford University Press 419-459, 1997

31 Hibi M, "IL-6 cytokine family and signal transduction:a model of the cytokine system" 74 (74): 1-12, 1996

32 Li L, "Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts" 125 (125): 460-469, 2003

33 Korean Federation of Internal Medicine, "Harrison's Internal Medicine" Do Seo Publising MIP 1937-1950, 2006

34 Choi EJ, "Enterococcus faecalis EF-2001 protects DNBS-induced inflammatory bowel disease in mice model" 14 (14): e0210854-, 2019

35 Kwak MS, "Emerging trends of inflammatory bowel disease in South Korea:a nationwide population-based study" 34 (34): 1018-1026, 2019

36 Briscoe D, "Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+T cell infiltration" 149 (149): 2954-2960, 1992

37 Korean Assosiation for the Study of Intestinal Diseases, "Easy to understand ulcerative colitis" Koonja 8-, 2003

38 명노일, "Dextran sulfate sodium으로 유도된 궤양성 대장염에 대한 와송의 억제효과" 대한본초학회 29 (29): 29-34, 2014

39 Neurath MF, "Cytokines in inflammatory bowel disease" 14 (14): 329-342, 2014

40 Diggle CP, "Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy" 49 (49): 1056-1062, 2010

41 "Classification of diseases (3 stage chronic disease) statistics"

42 Kim YK, "COX-2 inhibition and anti-inflammatory effects of traditional herbal medicine" 8 (8): 65-74, 2002

43 Marriott JB, "CC-3052:a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-αproduction" 161 (161): 4236-4243, 1998

44 Nakao A, "Biliverdin protects the functional integrity of a transplanted syngeneic small bowel" 127 (127): 595-606, 2004

45 Lin Z, "Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy" 25 (25): 1886-1895, 2019

46 Tracey KJ, "Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia" 330 (330): 662-664, 1987

47 Su C, "A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis" 132 (132): 516-526, 2007

48 Liang HL, "A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis" 14 (14): 114-, 2008